NYSE:TEVA

Teva Pharmaceutical Industries Stock News

Healthcare > Drug Manufacturers - Specialty & Generic

Buy TEVA

*Your capital is at risk

$32.83

-0.250 (-0.756%)

At Close: Jun 03, 2026

Generic drugs are most likely to face shortages due to market failures in affordability

05:26pm, Wednesday, 29'th Mar 2023

CNBC's Meg Tirrell joins 'Closing Bell Overtime' to discuss growing pharmaceutical shortages, increasing debt hindering generic drug availability, and more.

The Cream Of The Crop: 5 Biotech Stocks That Outrank 91% Of All Stocks

12:33pm, Friday, 24'th Mar 2023

The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.

7 Strong Buy Stocks Under $10 to Snap Up Now

06:30am, Thursday, 23'rd Mar 2023

Investors looking for a bargain and potential upside have strong buy stocks under $10 to consider. Investors should snap up companies that have value without sacrificing quality or growth.

Better Generics Pharmaceutical Stock: Teva or Viatris?

11:28am, Sunday, 05'th Mar 2023

Teva is the world's largest maker of generic drugs. Viatris offers an above-average dividend yield.

3 Generic Drug Stocks to Watch Amid Macro Headwinds

12:03pm, Friday, 03'rd Mar 2023

The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and TEVA.

Francisco Garcia Parames' Cobas Funds 4th-Quater Letter

06:01pm, Wednesday, 22'nd Feb 2023

Dear Investor:

Walmart, Home Depot And 3 Stocks To Watch Heading Into Tuesday

08:19am, Tuesday, 21'st Feb 2023 Benzinga

With US futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects The Home Depot, Inc. (NYSE: HD) to post quarterly ea

Competition Coming For AbbVie's Blockbuster Humira

01:08am, Thursday, 16'th Feb 2023

It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.

What To Expect From Teva Pharmaceutical In 2023 With A New CEO

02:37pm, Wednesday, 15'th Feb 2023

Anda's revenue generated $450 million for the company in the last three months of 2022, up $95 million from Q4 2022, driven by substantially increased demand for the company's services. Teva's Europea

Top Trades of David Abrams' Firm in the 4th Quarter

04:54pm, Monday, 13'th Feb 2023

David Abrams (Trades, Portfolio), founder of Abrams Capital Management, disclosed in a regulatory portfolio update filing that his firm's top trades during the fourth quarter included the transfer of

Axsome Therapeutics (AXSM) Stock Falls as Teva Pursues Generic Depression Drug

10:34am, Monday, 13'th Feb 2023

Axsome Therapeutics (NASDAQ: AXSM ) stock is taking a beating on Monday as rival Teva Pharmaceutical (NYSE: TEVA ) prepares a generic depression drug. According to a filing with the U.S. Securities an